NMPA Approval

Recombinant Human Erythropoietin β Injection (CHO Cell)

Approval Number

S20171007

Registration Date

August 25, 2017

Previous Approval Numbers

S20130049

Drug Information

Generic Name

重组人促红素-β注射液(CHO细胞)

Trade Name

罗可曼

Dosage Form

注射剂

Strength

2000IU/0.3ml/支

Drug Type

生物制品

Registration Date

August 25, 2017

Expiry Date

August 24, 2022

Company Address

Schoenmattstrasse 2,4153 Reinach, Switzerland

Company Address

Sandhoferstrasse 116 68305 Mannheim, Germany

Empowering clinical research with data-driven insights and AI-powered tools.

重组人促红素-β注射液(CHO细胞) - NMPA 批准文号 | MedPath